BREAKING: DCGI grants EUA to Covaxin for children between 6-12 yrs

The company has been asked to submit safety data including data on adverse events with due analysis every 15 days for the first two months and monthly after upto 5 months.  

Related Keywords

India ,Bharat , ,Drugs Controller General ,Bharat Biotech ,Covid 19 Vaccine ,Bharat Biotech Covid 19 Vaccine ,Covaxin ,Bharat Biotech Covaxin ,Ovaxin For Children Between 6 12 Yrs ,Cgi ,Drugs Controller General Of India ,